期刊文献+

MEK-1对MCF-7乳腺癌细胞αV整合素和上皮钙粘素调节的表达

Expression of MEK-1 in regulation of αV integrin and E-cadherin of MCF-7 breast cancer cells
暂未订购
导出
摘要 目的 :研究MEK 1在MCF 7乳腺癌细胞对αV整合素 (αVintegrin)和上皮钙粘素 (E cadherin)调节的表达。方法 :应用细胞转化技术把含有点突变的基因MEK 1整合进MCF 7乳腺癌细胞 ,使之成为含有整合基因MEK 1 GFP、Ala2 2 2 MEK 1 GFP、Asp2 2 2 MEK GFP的MCF 7乳腺癌细胞 ,通过免疫杂交和免疫荧光技术检测其表达水平的变化和在细胞内的定位。结果 :无活性的Ala2 2 2 MEK 1 GFP抑制MAPK的活性 ,增加上皮钙粘素的表达 ;活化的Asp2 2 2 MEK GFP增加MAPK的活性 ,不影响上皮钙粘素的表达 ;MEK 1 GFP和Asp2 2 2 MEK GFP上调αV整合素的表达 ,增加FAK磷酸化 ,Ala2 2 2 MEK 1 GFP不增加αV整合素的表达 ,抑制FAK的磷酸化。结论 :MEK调节αV整合素和上皮钙粘素的表达 ,而FAK是诱导整合素信号通路的重要因子 ,MEK可能通过调节整合素和上皮钙粘素的表达来调节FAK的磷酸化。 Purpose:Expression of MEK-1 was studied by regulating αV integrin and E-cadherin on MCF-7 breast cancer cells.Methods:Using cell transfected techniques site-mutated genes were inserted into MCF-7 cells and made MCF-7 cells containing MEK-1-GFP,Ala 222 MEK-1-GFP,Asp 222 MEK-1-GFP ,respectively. These cells were tested with immunoblot analysis and immunofluoresence technique to determined the change of MEK-1 expression and location of MEK-1 in cells.Results:Deactivated Ala 222 MEK-1-GFP inhibited the activity of MAPK,active Asp 222 MEK-1-GFP increased the activity of MAPK. Ala 222 MEK-1-GFP increased the expression of E-cadherin,did not increase the expression of αV integrin and inhibited FAK phosphorylation. MEK-1-GFP and Asp 222 MEK-1-GFP did not affect the expression of E-cadherin ,but upregulated the expression of αV integrin,increased FAK phosphorylation.Conclusions:MEK-1 regulated the expression of αV integrin and E-cadherin,FAK is the key factor that induced signal pathway of αV integrin. It is possible that MEK-1 regulated FAK phosphorglation by regulating expression of αV integrin and E-cadherin.
作者 蔡勇 张连峰
出处 《中国癌症杂志》 CAS CSCD 2003年第6期511-514,共4页 China Oncology
关键词 MEK-1 αV整合素 上皮钙粘素 培养的肿瘤细胞 MEK-1 αV integrin E-cadherin cultured tumor cells
  • 相关文献

参考文献12

  • 1[1]Hynes RO. Integrins: a family of cell surface receptors[J].Cell, 1987,48 (4) :549 - 554.
  • 2[2]Giancotti FG, Ruoslahti E. Integrin signaling [ J ]. Science,1999,285(5430), 1028-1032.
  • 3[3]Akiyama SK, Olden K, Yamada KM. Fibronectin and integrins in invasion and metastasis [ J ]. Cancer Metastasis Rev, 1995,14(3), 173-189.
  • 4[4]Downer CS, Watt FM, Speight PM. Loss of alpha 6 and beta 4integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas [J]. J Pathol,1993,171 ( 3 ): 183-190.
  • 5[5]Wang F, Hansen RK, Radisky D,et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in threedimensional contexts [ J ]. J Natl Cancer Inst, 2002,94 ( 19 ):1494-1503.
  • 6[6]Davies G, Jiang WG, Mason MD. E-cadherin and associated molecules in the invasion and progression of prostate cancer[J].Oncol Rep, 1998, 5 (6), 1567-1576.
  • 7[7]Pages G, Brunet A , L'Allemain G. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1) [J]. Embo J, 1994,13(13),3003-1010.
  • 8[8]Shapiro PS, Vaisberg E, Hunt A J, et al. Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen [ J ]. J Cell Biol, 1998,142 ( 6 ) ,1533-1545.
  • 9[9]Gould VE, Gould KA. E-cadherin as tumor differentiation marker and as architectural determinant [ J ]. Hum Pathol, 1999,30( 11 ) :1273-1275.
  • 10[10]Christofori G, Semb H. The role ofthe cell-cadhesion molecule E-cadherin as a tumour-suppressor gene [ J ]. Trends Biochem Sci,1999,24( 1 ) :73-76.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部